The University of South Carolina College of Pharmacy is training the nation’s next generation of pharmacists and health scientists. In addition to providing an ACPE-accredited pharmacy education, our school is leading clinical, entrepreneurial and research efforts designed to boost South Carolina’s health outcomes and communities our graduates go on to serve.
Students are well-prepared for traditional and nontraditional pharmacy settings within one-of-a-kind centers, labs and experiences. Our faculty and staff are internationally renowned for clinical innovation, patient care and for empowering pharmacy students to transform health care globally.
South Carolina’s Best
Students can tap into local, national and international training opportunities in community, clinical and industry settings. When our high-quality education is combined with the school’s family atmosphere, strategic partnerships, preceptor network and vast professional development options, it’s no surprise 93% of students would choose South Carolina all over again.STUDENT EXPERIENCE
Carolinian Spotlight: Patti Fabel
When Patti Fabel was named executive director at USC’s Kennedy Pharmacy Innovation Center in 2017, the move marked a new phase in the clinical associate professor’s career.
Mungo Teaching Award winner: Alexander Gasparian
2023 Michael J. Mungo Undergraduate Teaching Award winner Alexander Gasparian breaks down complicated concepts and principles of pharmacy, one student at a time.
Health Watch: Managing diabetes during the holidays
Jennifer Clements, the director of pharmacy education for USC’s College of Pharmacy at the Greenville campus, urges individuals with diabetes to think ahead during the holidays, offering strategies beyond checking your blood sugar levels and counting carbohydrates.
Searching for hidden connections
A team of researchers, including several in the College of Pharmacy, are hoping to use the computing power of artificial intelligence to find subtle connections among the hundreds of drug-therapy studies published each year. The researchers are mining data on approved drugs and their outcomes, particularly in patients with HIV-associated neurocognitive disorders.